Home » Topics » BioWorld Science

BioWorld Science
RSS

BBB fails to slow down prions

Dec. 3, 2018

Separating graft attacks

Dec. 3, 2018

First patient enrolled in phase III study of JZP-258 for the treatment of idiopathic hypersomnia

Nov. 30, 2018

Positive phase II data presented, initiation of phase III pemphigus program announced for PRN-1008

Nov. 30, 2018

Positive topline data presented from ENLIGHTEN-2 phase III study of ALKS-3831

Nov. 30, 2018

Precedex approved for use in pediatric patients in Japan

Nov. 30, 2018

Takhzyro subcutaneous injection approved in Europe for the preventive treatment of HAE

Nov. 30, 2018

Phase III clinical study of Fycompa monotherapy meets primary endpoint

Nov. 30, 2018

Forge Therapeutics presents bacterial lpxC inhibitors

Nov. 30, 2018

KCNQ2/3 channel activators patented by Knopp Biosciences

Nov. 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...